KLEIN LAWRENCE OTTO (President and CEO) sold 2.6% of their position (25K shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.09M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 10/2/2026ACC: 0000907654-26-000104
DirectorOfficer· President and CEO
Since Aug 2024
-25K
Net shares
Net seller
$2.09M
Total sold
3
Open market trades
0B · 3S
5
Total transactions
25K acquired · 50K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+25K
Price / share
$7.80
Trade value
$195K
% of position
2.7%
10/1/2026
923.13K→948.13K
Common Stock
Direct
Shares
−16.25K
Price / share
$83.40
Trade value
$1.35M
% of position
1.7%
10/1/2026
948.13K→931.88K
Common Stock
Direct
Shares
−8.55K
Price / share
$84.03
Trade value
$718.75K
% of position
0.9%
10/1/2026
931.88K→923.33K
Common Stock
Direct
Shares
−200.00
Price / share
$84.78
Trade value
$16.96K
% of position
0.0%
10/1/2026
923.33K→923.13K
Total
Net shares
+0.00
Net value
-$1.90M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2026 | M · Option Exercise | +25K | $7.80 | $195K | 2.7% | 923.13K | 948.13K |
| Common Stock Direct | 10/1/2026 | S · Sale | −16.25K | $83.40 | $1.35M | 1.7% | 948.13K | 931.88K |
| Common Stock Direct | 10/1/2026 | S · Sale | −8.55K | $84.03 | $718.75K | 0.9% | 931.88K | 923.33K |
| Common Stock Direct | 10/1/2026 | S · Sale | −200.00 | $84.78 | $16.96K | 0.0% | 923.33K | 923.13K |
| Total | +0.00 | -$1.90M | ||||||
Derivative Transactions1
Employee Warrant (right to buy)
Direct
Converts to
Common Stock
25K shares
Shares
−25K
Strike price
7.8
Held after
1.53M
Exercisable
—
10/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Warrant (right to buy) Direct | Common Stock25K shares | 10/1/2026 | M · Option Exercise | −25K | 7.8 | — | 1.53M |